Status:
COMPLETED
Metabolic Syndrome Observation on a Regional Basis
Lead Sponsor:
AstraZeneca
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the study is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.
Eligibility Criteria
Inclusion
- Patient aged between 18 and 75 years
- Signed Informed consent
- Laboratory analysis (lipidic profile and glycemia) performed in the last year
Exclusion
- Pregnancy or breast feeding
- Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs
- Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT00933010
Start Date
October 1 2009
End Date
October 1 2010
Last Update
October 13 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research
Foligno, Italy
2
Research Site
Perugia, Italy
3
Research Site
Terni, Italy